Befotertinib for Patients with Pretreated EGFR T790M Mutated Locally Advanced or Metastatic NSCLC: Final Overall Survival Results from a Phase 2 Trial
Shun Lu,Yiping Zhang,Guojun Zhang,Jianying Zhou,Shundong Cang,Ying Cheng,Gang Wu,Peiguo Cao,Dongqing Lv,Hong Jian,Xiangming Jin,Chengshui Chen,Panwen Tian,Kai Wang,Guanming Jiang,Gongyan Chen,Qun Chen,Hui Zhao,Cuimin Ding,Renhua Guo, Guoping Sun, Bin Wang,Liyan Jiang,Zhe Liu,Jian Fang,Junquan Yang,Wu Zhuang,Yunpeng Liu,Jian Zhang,Yueyin Pan,Jun Chen,Qitao Yu,Min Zhao, Jiuwei Cui, Dianming Li, Tienan Yi, Zhuang Yu,Yan Yang,Yan Zhang,Xiuyi Zhi,Yunchao Huang,Rong Wu,Liangan Chen, Aimin Zang,Lejie Cao, Qingshan Li,Xiaoling Li,Yong Song,Donglin Wang,Shucai Zhang,Lieming Ding, Ling Zhang, Dong Ji, Zhilin Shen LUNG CANCER（2024）
关键词
Befotertinib,EGFR TKI,NSCLC,Overall survival
AI 理解论文
溯源树
样例
